Joseph Michael Fitzgerald - Feb 20, 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Group Pres, Cardiology
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Feb 20, 2024
Transactions value $
-$4,501,238
Form type
4
Date filed
2/22/2024, 04:19 PM
Previous filing
Feb 20, 2024
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$4.5M -68K -100% $66.22 0 Feb 20, 2024 By 401(k) F1, F2
holding BSX Common Stock 193K Feb 20, 2024 Direct
holding BSX Common Stock 4.89K Feb 20, 2024 By Child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan prior to the rebalance election by the reporting person.
F3 The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.